The principals of THE SAGE GROUP may own stock in the companies included in the research reports.

At the end of the first quarter 2010 we owned the following securities:

Abbott Laboratories, Inc.

Angiodynamics Inc.

The Medicines Company

According to
THE SAGE GROUP :

PAD is not just a leg problem. PAD is a marker for severe systemic atherosclerosis as evidenced by the high morbidity and mortality.

Research has shown that within 5 years approximately 50% will experience a cardiovascular event (defined as a heart attack or stroke) and 30% of these will be fatal.

This 5-year mortality rate is higher than that of breast cancer, coronary artery disease and stroke.

(Volume I and Volume II)